Cargando…

LASSO NTCP predictors for the incidence of xerostomia in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma

To predict the incidence of moderate-to-severe patient-reported xerostomia among head and neck squamous cell carcinoma (HNSCC) and nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiotherapy (IMRT). Multivariable normal tissue complication probability (NTCP) models were dev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Tsair-Fwu, Liou, Ming-Hsiang, Huang, Yu-Jie, Chao, Pei-Ju, Ting, Hui-Min, Lee, Hsiao-Yi, Fang, Fu-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385804/ https://www.ncbi.nlm.nih.gov/pubmed/25163814 http://dx.doi.org/10.1038/srep06217

Ejemplares similares

Patient- and therapy-related factors associated with the incidence of xerostomia in nasopharyngeal carcinoma patients receiving parotid-sparing helical tomotherapy
por: Lee, Tsair-Fwu, et al.
Publicado: (2015)

LASSO-based NTCP model for radiation-induced temporal lobe injury developing after intensity-modulated radiotherapy of nasopharyngeal carcinoma
por: Kong, Cheng, et al.
Publicado: (2016)

Using Multivariate Regression Model with Least Absolute Shrinkage and Selection Operator (LASSO) to Predict the Incidence of Xerostomia after Intensity-Modulated Radiotherapy for Head and Neck Cancer
por: Lee, Tsair-Fwu, et al.
Publicado: (2014)

Treatment of nasopharyngeal carcinoma by tomotherapy: five-year experience
por: Leung, Stephen Wan, et al.
Publicado: (2013)

Normal tissue complication probability model parameter estimation for xerostomia in head and neck cancer patients based on scintigraphy and quality of life assessments
por: Lee, Tsair-Fwu, et al.
Publicado: (2012)

Dosimetry of Submandibular Glands on Xerostomia for Nasopharyngeal Carcinoma
por: Pan, Xin-Bin, et al.
Publicado: (2021)

Predictors for improvement of xerostomia in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy
por: Pan, Xin-Bin, et al.
Publicado: (2019)

Evaluation of Radiation-induced Xerostomia in Patients with Nasopharyngeal Carcinomas
por: Mohammadi, Narmin, et al.
Publicado: (2007)

A Risk Prediction Model by LASSO for Radiation-Induced Xerostomia in Patients With Nasopharyngeal Carcinoma Treated With Comprehensive Salivary Gland–Sparing Helical Tomotherapy Technique
por: Teng, Feng, et al.
Publicado: (2021)

Oral shedding of human herpesviruses in patients undergoing radiotherapy/chemotherapy for head and neck squamous cell carcinoma is not affected by xerostomia
por: Palmieri, Michelle, et al.
Publicado: (2018)

Multivariate NTCP Model of Hypothyroidism After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma
por: Shen, Guanzhu, et al.
Publicado: (2021)

Radiation-induced secondary malignancies for nasopharyngeal carcinoma: a pilot study of patients treated via IMRT or VMAT
por: Lee, Hsiao-Fei, et al.
Publicado: (2018)

NTCP Modeling of Late Effects for Head and Neck Cancer: A Systematic Review
por: Stieb, Sonja, et al.
Publicado: (2021)

Impact of late toxicities on quality of life for survivors of nasopharyngeal carcinoma
por: Tsai, Wen-Ling, et al.
Publicado: (2014)

The Different Dose-Volume Effects of Normal Tissue Complication Probability Using LASSO for Acute Small-Bowel Toxicity during Radiotherapy in Gynecological Patients with or without Prior Abdominal Surgery
por: Lee, Tsair-Fwu, et al.
Publicado: (2014)

NTCP modeling and dose–volume correlations for acute xerostomia and dry eye after whole brain radiation
por: Mavroidis, Panayiotis, et al.
Publicado: (2021)

IMRT for head and neck cancer: reducing xerostomia and dysphagia
por: Wang, XiaoShen, et al.
Publicado: (2016)

Identification of a Prognostic Pyroptostic-Related Model for Head and Neck Squamous Cell Carcinoma Based on LASSO-Cox Regression Analysis
por: Wu, Donglei, et al.
Publicado: (2022)

Use Dose Bricks Concept to Implement Nasopharyngeal Carcinoma Treatment Planning
por: Wu, Jia-Ming, et al.
Publicado: (2014)

Prognostic nomogram of xerostomia for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy
por: Pan, Xin-Bin, et al.
Publicado: (2020)

Study of dosimetry and clinical factors for assessment of xerostomia in head and neck squamous cell carcinoma treated by intensity-modulated radiotherapy: A prospective study
por: Singla, Vrinda, et al.
Publicado: (2021)

Network-Based Predictors of Progression in Head and Neck Squamous Cell Carcinoma
por: Sanati, Nasim, et al.
Publicado: (2018)

Diagnostic Predictors of Immunotherapy Response in Head and Neck Squamous Cell Carcinoma
por: Meliante, Piero Giuseppe, et al.
Publicado: (2023)

Clinical implication in the use of the AAA algorithm versus the AXB in nasopharyngeal carcinomas by comparison of TCP and NTCP values
por: Bufacchi, Antonella, et al.
Publicado: (2020)

Dosimetric Parameters Related to Acute Radiation Dermatitis of Patients with Nasopharyngeal Carcinoma Treated by Intensity-Modulated Proton Therapy
por: Fang, Ko-Chun, et al.
Publicado: (2022)

Mammalian target of rapamycin and head and neck squamous cell carcinoma
por: Liao, Yu-Min, et al.
Publicado: (2011)

Development of a normal tissue complication probability (NTCP) model for radiation-induced hypothyroidism in nasopharyngeal carcinoma patients
por: Luo, Ren, et al.
Publicado: (2018)

Impact of xerostomia on the quality of life of patients submitted to head and neck radiotherapy
por: do Nascimento, Michele Lopes, et al.
Publicado: (2019)

Parotid gland radiation dose‐xerostomia relationships based on actual delivered dose for nasopharyngeal carcinoma
por: Lou, Jingjiao, et al.
Publicado: (2018)

A prediction model for xerostomia in locoregionally advanced nasopharyngeal carcinoma patients receiving radical radiotherapy
por: Li, Minying, et al.
Publicado: (2022)

Ferroptosis-related gene ATG5 is a novel prognostic biomarker in nasopharyngeal carcinoma and head and neck squamous cell carcinoma
por: Shi, Ming, et al.
Publicado: (2022)

Cutaneous Squamous Cell Carcinoma of the Head and Neck
por: Gurudutt, Vivek V., et al.
Publicado: (2011)

Hypoxia in Head and Neck Squamous Cell Carcinoma
por: Li, John Zenghong, et al.
Publicado: (2012)

Immunotherapy for head and neck squamous cell carcinoma
por: Fuereder, Thorsten
Publicado: (2016)

Immunotherapy for Head and Neck Squamous Cell Carcinoma
por: Moskovitz, Jessica, et al.
Publicado: (2018)

Exosomes in Head and Neck Squamous Cell Carcinoma
por: Xiao, Cheng, et al.
Publicado: (2019)

Predictors of Extracapsular Extension in Patients With Squamous Cell Carcinoma of the Head and Neck and Outcome Analysis
por: Vengaloor Thomas, Toms, et al.
Publicado: (2021)

Gene alterations as predictors of radiation-induced toxicity in head and neck squamous cell carcinoma
por: Sumner, Whitney, et al.
Publicado: (2021)

Arterial lactate as a predictor of postoperative complications in head and neck squamous cell carcinoma
por: Souza, Suzane Pereira de, et al.
Publicado: (2021)

Predictors for Survival of Patients with Squamous Cell Carcinoma of Unknown Primary in the Head and Neck Region
por: Wagner, Steffen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_heuc7h9s6oa5hnbboql6gh45tl